Wojciech Danysz
Wojciech Danysz
Merz Pharmaceuticals
Bestätigte E-Mail-Adresse bei freenet.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist—a review of preclinical data
CG Parsons, W Danysz, G Quack
Neuropharmacology 38 (6), 735-767, 1999
10851999
Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications
W Danysz, CG Parsons
Pharmacological reviews 50 (4), 597-664, 1998
8051998
Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system-too little activation is bad, too much is even worse
CG Parsons, A Stöffler, W Danysz
Neuropharmacology 53 (6), 699-723, 2007
6572007
Glutamate in CNS disorders as a target for drug development: an update.
CG Parsons, W Danysz, G Quack
Drug news & perspectives 11 (9), 523-569, 1998
5091998
Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine–searching for the connections
W Danysz, CG Parsons
British journal of pharmacology 167 (2), 324-352, 2012
4392012
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
W Danysz, CG Parsons
International journal of geriatric psychiatry 18 (S1), S23-S32, 2003
4262003
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents—preclinical studies
W Danysz, CG Parsons, J Kornhuber, WJ Schmidt, G Quack
Neuroscience & Biobehavioral Reviews 21 (4), 455-468, 1997
3911997
Neuroprotective and symptomatological action of memantine relevant for Alzheimer’s disease—a unified glutamatergic hypothesis on the mechanism of action
W Danysz, CG Parsons, HJÖ MÖbius, A StÖffler, GÜ Quack
Neurotoxicity research 2 (2-3), 85-97, 2000
3842000
Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo
CG Parsons, G Quack, I Bresink, L Baran, E Przegalinski, W Kostowski, ...
Neuropharmacology 34 (10), 1239-1258, 1995
3251995
Glutamate in CNS disorders
W Danysz, CG Parsons, I Bresink, G Quack
Drug News and Perspectives 8, 261-261, 1995
2791995
Learning impairment in rats by N-methyl-D-aspartate receptor antagonists
W Danysz, JT Wroblewski, E Costa
Neuropharmacology 27 (6), 653-656, 1988
2581988
Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer’s disease
CG Parsons, W Danysz, A Dekundy, I Pulte
Neurotoxicity research 24 (3), 358-369, 2013
2422013
Modulation of L-DOPA-induced abnormal involuntary movements by clinically tested compounds: further validation of the rat dyskinesia model
A Dekundy, M Lundblad, W Danysz, MA Cenci
Behavioural brain research 179 (1), 76-89, 2007
2282007
Modulation of glutamate receptors: molecular mechanisms and functional implications
JT Wroblewski, W Danysz
Annual Review of Pharmacology and Toxicology 29 (1), 441-474, 1989
2251989
Modulation of learning processes by ionotropic glutamate receptor ligands.
W Danysz, W Zajaczkowski, CG Parsons
Behavioural pharmacology, 1995
2211995
Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats
Z Rogóż, G Skuza, J Maj, W Danysz
Neuropharmacology 42 (8), 1024-1030, 2002
2132002
Antagonism of metabotropic glutamate receptor type 5 attenuates l‐DOPA‐induced dyskinesia and its molecular and neurochemical correlates in a rat model of …
F Mela, M Marti, A Dekundy, W Danysz, M Morari, MA Cenci
Journal of neurochemistry 101 (2), 483-497, 2007
2122007
Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization
CG Parsons, W Danysz, G Quack, S Hartmann, B Lorenz, C Wollenburg, ...
Journal of Pharmacology and Experimental Therapeutics 283 (3), 1264-1275, 1997
2081997
Glutamate antagonists have different effects on spontaneous locomotor activity in rats
W Danysz, U Essmann, I Bresink, R Wilk
Pharmacology Biochemistry and Behavior 48 (1), 111-118, 1994
2001994
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests
IV Belozertseva, T Kos, P Popik, W Danysz, AY Bespalov
European neuropsychopharmacology 17 (3), 172-179, 2007
1962007
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20